BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23080193)

  • 21. IL-17C/IL-17 Receptor E Signaling in CD4
    Krohn S; Nies JF; Kapffer S; Schmidt T; Riedel JH; Kaffke A; Peters A; Borchers A; Steinmetz OM; Krebs CF; Turner JE; Brix SR; Paust HJ; Stahl RAK; Panzer U
    J Am Soc Nephrol; 2018 Apr; 29(4):1210-1222. PubMed ID: 29483158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases.
    Yamagata T; Skepner J; Yang J
    Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):405-14. PubMed ID: 26358867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural Insights into the Interleukin-17 Family Cytokines and Their Receptors.
    Liu S
    Adv Exp Med Biol; 2019; 1172():97-117. PubMed ID: 31628653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-17A-producing CD8(+)T cells as therapeutic targets in autoimmunity.
    Liang Y; Pan HF; Ye DQ
    Expert Opin Ther Targets; 2015 May; 19(5):651-61. PubMed ID: 25611933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E.
    Chang SH; Reynolds JM; Pappu BP; Chen G; Martinez GJ; Dong C
    Immunity; 2011 Oct; 35(4):611-21. PubMed ID: 21982598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting IL-17 and TH17 cells in chronic inflammation.
    Miossec P; Kolls JK
    Nat Rev Drug Discov; 2012 Oct; 11(10):763-76. PubMed ID: 23023676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the role of the innate immunity in autoimmune disease.
    Bachmann MF; Kopf M
    J Exp Med; 2001 Jun; 193(12):F47-50. PubMed ID: 11413199
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibiting RORγt/Th17 axis for autoimmune disorders.
    Isono F; Fujita-Sato S; Ito S
    Drug Discov Today; 2014 Aug; 19(8):1205-11. PubMed ID: 24792721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Th17 lymphocytes in bacterial infections].
    Szulc-Dąbrowska L; Gieryńska M; Depczyńska D; Schollenberger A; Toka FN
    Postepy Hig Med Dosw (Online); 2015 Apr; 69():398-417. PubMed ID: 25897100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eating the enemy within: autophagy in infectious diseases.
    Orvedahl A; Levine B
    Cell Death Differ; 2009 Jan; 16(1):57-69. PubMed ID: 18772897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer.
    Brevi A; Cogrossi LL; Grazia G; Masciovecchio D; Impellizzieri D; Lacanfora L; Grioni M; Bellone M
    Front Immunol; 2020; 11():565470. PubMed ID: 33244315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highlights in Autoimmunity: 2020.
    Toubi E; Vadasz Z
    Isr Med Assoc J; 2020 Nov; 11(22):717-719. PubMed ID: 33249794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The IL-17 family cytokines in immunity and disease.
    Pappu R; Ramirez-Carrozzi V; Ota N; Ouyang W; Hu Y
    J Clin Immunol; 2010 Mar; 30(2):185-95. PubMed ID: 20177959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toll-like receptors on the fork roads between innate and adaptive immunity.
    Abdelsadik A; Trad A
    Hum Immunol; 2011 Dec; 72(12):1188-93. PubMed ID: 21920397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting IL-17 and IL-23 in Immune Mediated Renal Disease.
    Ghali JR; Holdsworth SR; Kitching AR
    Curr Med Chem; 2015; 22(38):4341-65. PubMed ID: 26521930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble IL-4 receptor, potential for therapeutic and prophylactic intervention.
    Gessner A; Röllinghoff M
    Behring Inst Mitt; 1994 Dec; (95):35-41. PubMed ID: 7755507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy.
    Kramer JM; Gaffen SL
    J Periodontol; 2007 Jun; 78(6):1083-93. PubMed ID: 17539723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of the IL-23/IL-17 axis and the Th17/Treg balance in the pathogenesis and control of autoimmune arthritis.
    Astry B; Venkatesha SH; Moudgil KD
    Cytokine; 2015 Jul; 74(1):54-61. PubMed ID: 25595306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-17+Foxp3+ T cells: an intermediate differentiation stage between Th17 cells and regulatory T cells.
    Du R; Zhao H; Yan F; Li H
    J Leukoc Biol; 2014 Jul; 96(1):39-48. PubMed ID: 24744433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Th17 cytokines and mucosal immunity.
    Dubin PJ; Kolls JK
    Immunol Rev; 2008 Dec; 226():160-71. PubMed ID: 19161423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.